| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5845717 | Pulmonary Pharmacology & Therapeutics | 2014 | 5 Pages |
Abstract
In HF, the down-regulation of pulmonary β-ARs results in a significant attenuation of airway relaxation. These effects have been reversed by a treatment with metoprolol, suggesting a potential role of β-AR blockers in the treatment of patients suffering from HF and chronic obstructive airway diseases.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
B. Rinaldi, A. Capuano, G. Gritti, M. Donniacuo, A. Scotto Di Vettimo, L. Sodano, C. Rafaniello, F. Rossi, M.G. Matera,